Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Bio-Rad Laboratories stock (BIO)

Buy Bio-Rad Laboratories stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Bio-Rad Laboratories is a medical devices business based in the US. Bio-Rad Laboratories shares (BIO) are listed on the NYSE and all prices are listed in US Dollars. Bio-Rad Laboratories employs 8,000 staff and has a trailing 12-month revenue of around $2.6 billion.

Our top picks for where to buy Bio-Rad Laboratories stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Bio-Rad Laboratories stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BIO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Bio-Rad Laboratories stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Bio-Rad Laboratories stock price (NYSE: BIO)

Use our graph to track the performance of BIO stocks over time.

Bio-Rad Laboratories shares at a glance

Information last updated 2024-07-21.
Latest market close$315.17
52-week range$261.59 - $431.79
50-day moving average $286.97
200-day moving average $307.16
Wall St. target price$343.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-10.69

Is it a good time to buy Bio-Rad Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bio-Rad Laboratories price performance over time

Historical closes compared with the close of $315.17 from 2024-07-25

1 week (2024-07-19) 6.18%
1 month (2024-06-27) 15.88%
3 months (2024-04-26) 14.22%
6 months (2024-01-26) -4.22%
1 year (2023-07-27) -25.34%
2 years (2022-07-27) -42.35%
3 years (2021-07-27) 702.79
5 years (2019-07-26) 324.38

Is Bio-Rad Laboratories stock undervalued or overvalued?

Valuing Bio-Rad Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bio-Rad Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bio-Rad Laboratories's PEG ratio

Bio-Rad Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1905. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bio-Rad Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Bio-Rad Laboratories's EBITDA

Bio-Rad Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $503 million.

The EBITDA is a measure of a Bio-Rad Laboratories's overall financial performance and is widely used to measure a its profitability.

Bio-Rad Laboratories financials

Revenue TTM $2.6 billion
Operating margin TTM 8.48%
Gross profit TTM $1.6 billion
Return on assets TTM 1.69%
Return on equity TTM -3.43%
Profit margin -12.37%
Book value $317.32
Market Capitalization $8.5 billion

TTM: trailing 12 months

Bio-Rad Laboratories share dividends

We're not expecting Bio-Rad Laboratories to pay a dividend over the next 12 months.

Have Bio-Rad Laboratories's shares ever split?

Bio-Rad Laboratories's shares were split on a 2:1 basis on 7 March 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bio-Rad Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bio-Rad Laboratories shares which in turn could have impacted Bio-Rad Laboratories's share price.

Bio-Rad Laboratories share price volatility

Over the last 12 months, Bio-Rad Laboratories's shares have ranged in value from as little as $261.59 up to $431.79. A popular way to gauge a stock's volatility is its "beta".

BIO.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bio-Rad Laboratories's is 0.93. This would suggest that Bio-Rad Laboratories's shares are less volatile than average (for this exchange).

Bio-Rad Laboratories overview

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc.

Frequently asked questions

null
What percentage of Bio-Rad Laboratories is owned by insiders or institutions?
Currently 15.196% of Bio-Rad Laboratories shares are held by insiders and 82.578% by institutions.
How many people work for Bio-Rad Laboratories?
Latest data suggests 8,000 work at Bio-Rad Laboratories.
When does the fiscal year end for Bio-Rad Laboratories?
Bio-Rad Laboratories's fiscal year ends in December.
Where is Bio-Rad Laboratories based?
Bio-Rad Laboratories's address is: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
What is Bio-Rad Laboratories's ISIN number?
Bio-Rad Laboratories's international securities identification number is: US0905722072
What is Bio-Rad Laboratories's CUSIP number?
Bio-Rad Laboratories's Committee on Uniform Securities Identification Procedures number is: 090572207

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site